Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · Real-Time Price · USD

1.410

+0.030 (2.17%)

At close: Aug 28, 2026, 4:00 PM EDT

1.410

0.00 (0.00%)

After-hours: Aug 28, 2026, 4:10 PM EDT

Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.98	14.69	19.53	0.17	2.03	19.56
Short-Term Investments	-	0.08	0.07	0.06	0.05	0.4
Cash & Short-Term Investments	16.98	14.77	19.61	0.22	2.08	19.96
Cash Growth	-4.60%	-24.66%	8731.08%	-89.33%	-89.58%	5353.01%
Other Receivables	1.31	0.9	2.23	0.95	0.87	1.35
Receivables	1.31	0.9	2.23	0.95	0.87	1.35
Prepaid Expenses	3.38	2.11	0.51	0.78	0.59	0.04
Other Current Assets	0.06	0.15	-	0.02	1.43	0.07
Total Current Assets	31.73	17.93	22.34	1.97	4.97	21.4
Property, Plant & Equipment	0.39	0.33	0.31	0.02	0.03	0.09
Other Intangible Assets	-	-	-	9.87	9.55	28.14
Total Assets	32.12	18.26	22.65	11.86	14.54	49.63

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.11	4.28	4.18	8.42	6.25	0.7
Accrued Expenses	1.48	2.52	2.46	1.25	1.9	8.59
Short-Term Debt	20.86	-	-	-	2.64	-
Current Portion of Long-Term Debt	1.42	1.4	1.35	1.3	-	-
Current Portion of Leases	-	-	-	-	0.01	0.1
Current Income Taxes Payable	0.08	0.08	0.07	0.06	0.04	0.06
Other Current Liabilities	0.62	0.15	2.78	3.14	0.37	11.27
Total Current Liabilities	28.58	8.43	10.84	14.17	11.22	20.72
Long-Term Debt	-	-	-	-	1.08	0.98
Long-Term Leases	-	-	-	-	-	0.01
Long-Term Deferred Tax Liabilities	-	-	-	0.45	0.35	1.96
Other Long-Term Liabilities	-	-	-	-	-	7.18
Total Liabilities	28.58	8.43	10.84	14.61	12.65	30.85

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	-	-	0
Additional Paid-In Capital	144.68	144.23	131.13	90.37	83.16	85.24
Retained Earnings	-136.35	-130.2	-118.97	-94.45	-82.55	-66.49
Treasury Stock	-3.45	-3.19	-	-	-	-
Comprehensive Income & Other	-1.35	-1.02	-0.35	-0.41	-0.72	-0.6
Total Common Equity	3.54	9.83	11.81	-4.49	-0.11	18.15
Shareholders' Equity	3.54	9.83	11.81	-2.75	1.89	18.78
Total Liabilities & Equity	32.12	18.26	22.65	11.86	14.54	49.63

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	22.29	1.4	1.35	1.3	3.74	1.09
Net Cash (Debt)	-5.3	13.37	18.26	-1.08	-1.66	18.87
Net Cash Growth	-	-26.76%	-	-	-	-
Net Cash Per Share	-0.34	0.93	11.36	-	-	-
Filing Date Shares Outstanding	15.91	15.82	17.01	0.01	0	0
Total Common Shares Outstanding	15.91	19.03	7.3	-	0	0
Working Capital	3.15	9.5	11.5	-12.2	-6.25	0.69
Book Value Per Share	0.22	0.52	1.62	-	-5947.37	1815200.00
Tangible Book Value	3.54	9.83	11.81	-14.36	-9.66	-9.98
Tangible Book Value Per Share	0.22	0.52	1.62	-	-508526.32	-998300.00

SEC Filings: 10-K · 10-Q